Cresco Labs
(OTCQX:CRLBF)
$2.07
-0.02[-0.96%]
At close: May 16
$2.07
0[0.00%]
After Hours: 4:00PM EDT
The most recent conference call was at 8:30 AM, 1 day ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Cresco Labs Stock (OTC:CRLBF), Quotes and News Summary

Cresco Labs Stock (OTC: CRLBF) stock price, news, charts, stock research, profile.

Open$2.120
Close$2.220
Volume / Avg.1.814M / 887.792K
Day Range2.060 - 2.350
52 Wk Range1.000 - 2.770
Market Cap$703.196M
P/E Ratio-
Dividend Yield-
ExchangeOTC
RSI
0
Short Interest-
Days to Cover1

Recent News

Cresco Labs CEO Touts 10x Increase In Operating Cash Flow YoY As Cannabis Company Reports Q1 Results
Cannabis producer Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) announced on Wednesday its financial and operating results for the first quarter ended March 31, 2024. "I want to thank the Cresco team for taking our learnings from the Year-of-the-Core, making them a part of our DNA and producing such a strong start to 2024," Charles Bachtell, CEO of Cresco Labs, said. "The continued development of our teams' capabilities and our relentless focus on efficient execution is leading to very strong performance across our retail and branded product business resulting in a 10x increase in operating cash flow year-over-year."
Jelena Martinovic
Florida Cannabis Legalization Amendment Ads Hit Airwaves: The First 4 Pitches For Legal Weed In The Sunshine State
The advocacy group's ads are being aired across the state over TV, radio, streaming and on digital sites. Having spent more than $5 million, the ads are criss-crossing the state to bring attention to Florida's upcoming November election and Amendment 3.
Maureen Meehan
Medical Marijuana Giant Trulieve, Backer Of Florida's Recreational Cannabis Ballot, Narrows Loss, Reports Uptick In Q1 Revenue, Gross Profit
Trulieve Cannabis Corp. announced on Thursday its first quarter results for the three months ended March 31, 2024. The Tallahassee, Florida-based medical cannabis giant reported revenue of $298 million for the first quarter of fiscal 2024, representing an increase of 4% sequentially and year-over-year, with 96% of revenue from retail sales.
Jelena Martinovic
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Mar
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.4
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CRLBF

FAQ

Q

How do I buy Cresco Labs (CRLBF) stock?

A

You can purchase shares of Cresco Labs (OTCQX: CRLBF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cresco Labs's (CRLBF) competitors?

A

There are no as such competitors for Cresco Labs.

Q

What is the target price for Cresco Labs (CRLBF) stock?

A

The latest price target for Cresco Labs (OTCQX: CRLBF) was reported by Wedbush on Thursday, May 16, 2024. The analyst firm set a price target for 3.00 expecting CRLBF to rise to within 12 months (a possible 44.93% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Cresco Labs (CRLBF)?

A

The stock price for Cresco Labs (OTCQX: CRLBF) is $2.07 last updated Today at May 16, 2024 at 4:00 PM EDT.

Q

Does Cresco Labs (CRLBF) pay a dividend?

A

There are no upcoming dividends for Cresco Labs.

Q

When is Cresco Labs (OTCQX:CRLBF) reporting earnings?

A

Cresco Labs’s Q2 earnings are confirmed for Wednesday, August 14, 2024.

Q

Is Cresco Labs (CRLBF) going to split?

A

There is no upcoming split for Cresco Labs.

Q

What sector and industry does Cresco Labs (CRLBF) operate in?

A

Cresco Labs is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQX.